Dr Robin Hesketh

University of Cambridge

University departments
Department of Biochemistry

Position: Senior Lecturer
Personal home page: http://www.bioc.cam.ac.uk/uto/hesketh.html

PubMed journal articles - click here

Research description

I am based in the Biochemistry Department and work on several cancer related projects, primarily in collaboration with Jim Metcalfe, Kevin Brindle and Doug Easton. These fall into four areas (1) Development of anti-angiogenic gene therapy, (2) Studies of transforming growth factor beta (TGF?), (3) Studies on a breast cancer-associated gene, TOX3, and (4) Studies of gene expression and metabolomic profiles in response to electromagnetic fields.

Research Programme
Advanced Cancer Imaging
trh12
Recent publications:
 Retrieving latest data from feed...

Symplectic Elements feed provided by Research Information, University of Cambridge


Key publications

Griggs, J., Smith, G.A., Brindle, K.M., Metcalfe, J.C. and Hesketh, R. (2002). Inhibition of proliferative retinopathy by the antivascular agent combretastatin-A4. Amer. J. Pathology, 160, 1097-1103. L├╝cke, C.D., Philpott, A., Metcalfe, J.C., Thompson, A.M., Hughes-Davies, L., Kemp, P.R. and Hesketh, R. (2001). Inhibiting mutations in the transforming growth factor ? type 2 receptor in recurrent human breast cancer. Cancer Research, 61, 482-485. Griggs, J., Hesketh, R., Smith, G.A., Brindle, K.M., Metcalfe, J.C., Thomas, G.A. and Williams, E.D. (2001). Combretastatin-A4 disrupts neo-vascular development in non-neoplastic tissue. British Journal of Cancer, 84, 832-835.